tradingkey.logo
tradingkey.logo
Search

Neurocrine Biosciences Initiates Phase 3 Registrational Program For NBI-1117568

ReutersApr 30, 2025 12:04 PM
facebooktwitterlinkedin
View all comments0

- Neurocrine Biosciences Inc NBIX.O:

  • NEUROCRINE BIOSCIENCES INITIATES PHASE 3 REGISTRATIONAL PROGRAM FOR NBI-1117568 AS POTENTIAL TREATMENT FOR ADULTS WITH SCHIZOPHRENIA

  • NEUROCRINE BIOSCIENCES INC - PHASE 3 STUDY TO ENROLL APPROXIMATELY 280 SCHIZOPHRENIA PATIENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI